Artificial heart maker CARMAT gets regulatory approvals to resume sales | Inquirer News

Artificial heart maker CARMAT gets regulatory approvals to resume sales

/ 02:25 PM October 25, 2022

Artificial heart maker CARMAT

 Chief Executive Officer of French artificial heart manufacturer Carmat, Stephane Piat, poses holding an artificial heart during an interview with Reuters in Velizy, near Paris, January 11, 2021. REUTERS FILE PHOTO

PARIS — French medical devices company CARMAT said it had received the necessary regulatory approvals to resume commercial implants of its Aeson artificial hearts product and would resume sales soon.

“We will be resuming implants very soon and moving forward at a measured pace as we continue building our inventory of implantable prostheses, and ensure all patients are suitably monitored,” Chief Executive Stéphane Piat said in a statement.

ADVERTISEMENT

RELATED STORIES

FEATURED STORIES

French firm announces first implant of its artificial heart in a woman

79-year-old with artificial heart reaches 1,000-day milestone

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Artificial Heart, Carmat, Health, medicine, technology

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.